Altered blood thiamine metabolism in Alzheimer's disease

chunjiu zhong,xiaoli pan,guoqiang fei,jingwen lu

DOI: https://doi.org/10.1016/j.jalz.2013.04.056

2013-01-01

Alzheimer s & Dementia

Abstract:Reduced cerebral glucose metabolism is an invariant feature in Alzheimer's disease. A key coenzyme of glucose metabolism and the active form of thiamine, thiamine diphosphate, has been shown to be significantly reduced in Alzheimer's disease. Altered blood thiamine metabolism may represent a usefulbiomarker for the diagnosis of Alzheimer's disease. Control subjects with normal cognition (n=500) and patients with Alzheimer's disease(n=110) and vascular dementia (n=53) were recruited. Blood thiamine diphosphate, thiamine monophosphate and thiamine levels as well as the activities of blood thiamine pyrophosphokinase were measured using high performance liquid chromatography. Bloodthiamine diphosphatelevels in patients with Alzheimer's disease were significantly decreased as compared with control subjects (82.31±2.23 vs. 118.60±1.12 nmol/L, P<0.001), whereas bloodthiamine monophosphateand thiamine levels were increased (5.27±0.47 vs. 3.59±0.09 nmol/L, P<0.001 and 4.21±0.42 vs. 3.41±0.11 nmol/L, P<0.01). Bloodthiamine diphosphatelevel exhibited significantly diagnostic value, with an area under receiver operating characteristic curve (AUC)of 0.871, a sensitivity of 80.00% and a specificity of 79.60%. The ratio of blood thiamine diphosphate level over seventh square root of blood thiamine level exhibited an even higher diagnostic value, with an AUC of 0.893, a sensitivity of 80.00% and a specificity of 84.00% when the cut-off point was 85.16. Over two-thirds of patients with vascular dementiawere above this cut-off point and could be differentiated from patients with Alzheimer's disease. In Alzheimer's disease patients with APOE ε4 alleles, the ratio of blood thiamine diphosphate level over seventh square root of blood thiamine level exhibited an excellent diagnostic power with an AUC of 0.906, a sensitivity of 82.69% and a specificity of 84.60%. Of mechanism, altered blood thiamine metabolism was associated with reduced activities of thiamine pyrophosphokinase in patients with Alzheiemr's disease as compared with control subjects (1.24 ± 0.06 vs. 1.44 ± 0.07, P<0.05). The patients with Alzheimer's disease manifest significant abnormality in blood thiamine metabolism as compared with normal cognitive subjects and patients with vascular dementia. Altered blood thiamine metabolism represents an ideal diagnostic biomarker for Alzheimer's disease with the reliable, non-invasive, simple to perform and inexpensive merits, and is associated with decreased thiamine pyrophosphokinase activities.